Similar findings implicating the CD8 pathway were noted in a case-controlled study of 30 LC patients and 20 controlled with a significant increase in the levels of CD8+ T cells for the LC group relative to the recovered group [53]. The gene discussed is CD8A; the disease is laryngotracheoesophageal cleft.